The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow IPOs

By The Online Investor Staff, updated Fri., Aug. 1, 3:46 AM

Slide #1. Marinus Pharmaceuticals, Inc. Initial Public Offering

Company: Marinus Pharmaceuticals, Inc.
Proposed Symbol: MRNS
Shares Offered: 5,625,000
Price Per Share: $8
Over-Allotment: 843,750
Description: Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative neuropsychiatric therapeutics, today announced the pricing of its initial public offering of 5,625,000 shares of its common stock at a public offering price of $8.00 per share, before underwriting discounts. The shares are scheduled to begin trading on the NASDAQ Global Market under the ticker symbol "MRNS" on July 31, 2014. In addition, Marinus has granted the underwriters a 30-day option to purchase up to an additional 843,750 shares of common stock at the same price to cover over-allotments, if any. The offering is expected to close on August 5, 2014, subject to customary closing conditions.

IPOs: Marinus Pharmaceuticals, Inc.

List of IPOs in this Slideshow:
Company                                 Ticker    IPO Date
Virgin America Inc.                     T.B.D.    
ContraFect Corporation                  CFRX      
Green Bancorp, Inc.                     GNBC      
Bio Blast Pharma Ltd.                   ORPN      
Synchrony Financial                     SYF       
Macrocure Ltd.                          MCUR      
HealthEquity, Inc.                      HQY       
VBL Therapeutics                        VBLX      
Catalent, Inc.                          CTLT      
Avalanche Biotechnologies, Inc.         AAVL      
Paramount Group, Inc.                   T.B.D.    
Transocean Partners LLC                 RIGP      
TransFirst Inc.                         T.B.D.    
Westlake Chemical Partners LP           WLKP      
Marinus Pharmaceuticals, Inc.           MRNS      

August 1, 2014    3:46 AM Eastern

IPOs | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.